Obolenskoye Pharmaceutical Company

Obolenskoye Pharmaceutical Company is a prominent Russian pharmaceutical manufacturer specializing in the development and production of high-quality generic medications. Founded in 1994 and based in the Moscow region, the company maintains a diverse portfolio of over 150 products across therapeutic areas such as gastroenterology, cardiology, and neurology. In 2019, Obolenskoye merged with Binnopharm to form the Alium group, which subsequently became part of Binnopharm Group, one of Russia's largest pharmaceutical holdings. The company operates modern GMP-compliant manufacturing facilities and provides contract manufacturing services to international partners. Its business model focuses on increasing the accessibility of essential medicines within the Russian and CIS markets.